Antiretroviral therapy-associated toxicities in the resource-poor world: the challenge of a limited formulary

The Journal of Infectious Diseases
Richard A MurphyRajesh T Gandhi

Abstract

Toxicities related to antiretroviral therapy make long-term adherence to therapy difficult for patients and present challenges to providers, especially those in the resource-poor world who work with a limited formulary. In resource-poor settings, where limited drug options are the rule, when and how to change therapy are especially difficult problems. Drugs such as stavudine and didanosine are associated with serious metabolic complications, such as lactic acidosis, pancreatitis, and peripheral neuropathy. Antiretroviral agents associated with fewer metabolic effects, such as tenofovir and abacavir, remain widely unavailable. Because the current formulary restrictions appear to be unlikely to change quickly, providers in resource-poor countries must be familiar with the common adverse events-including metabolic complications, hypersensitivity reactions, anemia, and liver enzyme abnormalities-and must understand how to manage them with what is locally available. Most importantly, to avoid drug toxicities, a larger formulary is needed in resource-poor settings, and this must be a high priority for policy makers and health care professionals involved in treating human immunodeficiency virus infection globally.

References

Jan 8, 1999·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·G J Moyle, M Sadler
Aug 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M BessesenK E Sherman
Aug 25, 1999·The Journal of Antimicrobial Chemotherapy·B AllaouchicheD Chassard
Nov 14, 2000·American Journal of Hematology·A Majluf-CruzL Nieto-Cisneros
Dec 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C HadiganS Grinspoon
Jan 12, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Mark S SulkowskiRichard D Moore
Mar 15, 2002·The New England Journal of Medicine·Hélène C F CôtéJulio S G Montaner
May 23, 2002·Clinical Therapeutics·William SymondsSeth Hetherington
Jun 28, 2002·The New England Journal of Medicine·Sharon WalmsleyUNKNOWN M98-863 Study Team
Feb 27, 2003·Archives of Medical Research·Patricia Cornejo-JuárezPatricia Volkow-Fernández
Nov 25, 2003·The New England Journal of Medicine·Nina Friis-MøllerUNKNOWN Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group
Dec 12, 2003·The New England Journal of Medicine·Gregory K RobbinsUNKNOWN AIDS Clinical Trials Group 384 Team
Dec 31, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Grace A McComseyUNKNOWN Trial to Assess the Regression of Hyperlactatemia and to Evaluate the Regression of Established Lipodystrophy in HIV-1-Posit
Mar 17, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Melisse Sloas Baylor, Rosemary Johann-Liang
Apr 24, 2004·Antimicrobial Agents and Chemotherapy·C J L la PorteD M Burger
Jul 14, 2004·JAMA : the Journal of the American Medical Association·Joel E GallantUNKNOWN 903 Study Group
Oct 27, 2004·Journal of Neurology·K HahnUNKNOWN German Neuro-AIDS Working Group
Apr 30, 2005·Tropical Medicine & International Health : TM & IH·Joep J van OosterhoutEduard E Zijlstra
Dec 13, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Nagalingeswaran KumarasamyKenneth H Mayer
Feb 14, 2006·Mayo Clinic Proceedings·Sergio FerrariZelalem Temesgen
Jun 8, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A RauchSimon Mallal
Jun 29, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Barbara H McGovernPatricia L Hibberd

❮ Previous
Next ❯

Citations

Jun 10, 2010·Current HIV/AIDS Reports·Jennifer Cohn, Brook Baker
Oct 7, 2008·Transactions of the Royal Society of Tropical Medicine and Hygiene·Johan van GriensvenTony Reid
Nov 4, 2008·Journal of Laparoendoscopic & Advanced Surgical Techniques. Part a·Behrouz Banieghbal
May 11, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Diane E BennettKaren F Kelley
Oct 26, 2011·The Journal of Infectious Diseases·Victoria O KasprowiczAjit Lalvani
Jun 13, 2013·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Richard J LessellsMarie-Louise Newell
Apr 10, 2010·American Journal of Respiratory and Critical Care Medicine·Zegabriel TedlaTaraz Samandari
Jan 17, 2014·AIDS Research and Therapy·Corinne Tchoula MamiafoJeanne Ngogang Yonkeu
Apr 25, 2012·International Journal of Hematology·Michael J WebbVernon J Louw
Feb 26, 2013·Médecine et maladies infectieuses·E S Bayonne Kombo, A Gathse
Oct 7, 2009·The American Journal of Medicine·Maija L HaanpääRalf Baron
Mar 5, 2014·Tropical Medicine & International Health : TM & IH·Alana T BrennanMatthew P Fox
Aug 10, 2016·Infectious Diseases in Obstetrics and Gynecology·Bassam H RimawiRana Chakraborty
Apr 18, 2009·Current Opinion in HIV and AIDS·Mohammed LamordeConcepta Merry
Mar 20, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Neel R GandhiUNKNOWN Tugela Ferry Care and Research (TFCaRes) Collaboration
Jan 5, 2010·Current Opinion in HIV and AIDS·Nathan Ford, Alexandra Calmy
Apr 11, 2012·World Journal of Hepatology·Megan CraneSharon R Lewin
May 31, 2019·Current Opinion in Allergy and Clinical Immunology·Jonny PeterRannakoe J Lehloenya

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
B Max, R Sherer
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
M G Bolhaar, A S Karstaedt
© 2021 Meta ULC. All rights reserved